Search Within

Shanu Modi

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (23)
  3. Review (2)
Groups
  1. Breast Medicine Service (62)
  2. Department of Medicine (62)
  3. GSK Faculty (62)
  4. Human Oncology and Pathogenesis Program (62)
  5. Solid Tumor Oncology Division (62)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (53)

More Groups

People
  1. Sarat Chandarlapaty (49)
  2. Clifford Hudis (34)
  3. Sujata Patil (24)
  4. Larry Norton (21)
  5. David Solit (16)
  6. Chau Dang (15)

More People

Years
  1. 2024 (6)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Cancer Research (15)
  3. Clinical Cancer Research (5)
  4. Breast Cancer Research and Treatment (3)
  5. npj Breast Cancer (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (20)
  3. Nature Publishing Group (6)
  4. Elsevier Inc. (3)
  5. Oxford University Press (3)
  6. Springer (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC)
    Meeting Abstract

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S.; Slovin, S. F.; Blinder, V. S.; Comen, E. A.; Danila, D. C.; Hoffman, D. M. J.; Kang, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO Clinical Practice Guideline update
    Journal Article

    Ramakrishna, N.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Esteva, F. J.; Giordano, S. H.; Kirshner, J. J.; Krop, I. E.; Levinson, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO clinical practice guideline update
    Journal Article

    Giordano, S. H.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Esteva, F. J.; Kirshner, J. J.; Krop, I. E.; Levinson, J.; Lin, N. U.; Modi, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Wang, R.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; more...
    Breast Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (pts) with solid tumors
    Meeting Abstract

    Modi, S.; Eder, J. P.; Lorusso, P.; Weekes, C.; Chandarlapaty, S.; Tolaney, S. M.; McLaughlin, J.; Camidge, D. R.; Chang, C. W.; Nazzal, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save